p56Dok-2(Phospho-Tyr351) Rabbit Polyclonal Antibody, 50ul Hybridoma Antibody Sequencing The main pharmacological distinction between

The main pharmacological distinction between the members of the purinoceptor family is the relative sensitivity to the antagonists suramin and PPADS

This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain

The encoded protein can bind geminin

This encoded protein can form a complex with the Golgi matrix protein GOLGA2

This gene encodes a predicted transmembrane protein containing two extracellular CUB domains followed by a low-density lipoprotein class A (LDLa) domain

p56Dok-2(Phospho-Tyr351) Rabbit Polyclonal Antibody, 50ul Hybridoma Antibody Sequencing The main pharmacological distinction betweenThe protein encoded by this gene is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr abl) a chimeric protein whose presence is associated with CML. This encoded protein binds p120 (RasGAP) from CML cells.